Corasin Tablet (Clonixin Lysine Salt)

Adult dose

○ Adults Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication may pose a risk of serious side effects such as gastrointestinal bleeding for individuals who regularly consume more than three alcoholic drinks per day; therefore, consultation with a doctor or pharmacist is essential. This drug can increase the risk of cardiovascular and vascular diseases, thus patients with cardiovascular diseases or risk factors should be particularly cautious, and if cardiovascular symptoms occur, immediate consultation with medical personnel is required. Severe issues such as gastrointestinal bleeding, ulcers, and perforation can occur, so elderly patients or those with a history of gastrointestinal diseases should carefully monitor their gastrointestinal status while taking this medication. Patients with a history of peptic ulcers, those who have experienced gastrointestinal disturbances due to medications, individuals who are allergic to this drug or its components, and those who have had allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs should not take this medication. Pregnant women or women who may become pregnant, patients with severe liver, kidney diseases or heart failure, and patients with inflammatory bowel disease should also avoid using this drug. Taking this medication with other non-steroidal anti-inflammatory drugs, ACE inhibitors, angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, anticoagulants, cyclosporine, tacrolimus, antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), or corticosteroids may increase the risk of side effects, so they should not be co-administered or should be monitored closely. Patients with a history of peptic ulcers or the elderly, as well as those with hypertension, heart failure, or liver/kidney disorders, must consult with their healthcare provider before taking this medication. If symptoms such as gastrointestinal bleeding, skin rash, difficulty breathing, signs of anemia, abnormalities in liver function, or neurological symptoms occur during use, discontinue taking the medication immediately and consult with medical personnel. This medication should be used at the minimum effective dose and for the shortest duration required; regular blood tests and liver/kidney function monitoring may be necessary with long-term use. Pregnant or breastfeeding women should avoid taking this medication, and if breastfeeding, should consult with healthcare professionals regarding medication administration or discontinuation of breastfeeding. This medication should be kept out of reach of children, and it is safer not to transfer it to another container.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, dysphoria, fluid retention, edema, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, exfoliative dermatitis, mucosal syndrome, toxic epidermal necrolysis, severe bronchospasm

This medication should be stored in a tightly sealed container to prevent air and moisture exposure, avoiding direct sunlight and storing it at room temperature. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance

White round film-coated tablets

Package unit

10 tablets/Foil